First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

Author： Aogi Kenjiro   Masuda Norikazu   Ohno Shinji   Oda Takashi   Iwata Hiroji   Kashiwaba Masahiro   Fujiwara Yasuhiro   Kamigaki Shunji   Ito Yoshinori   Ueno Takayuki   Takashima Shigemitsu  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.129, Iss.3, 2011-10, pp. : 829-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer

By Wist Erik Andreas   Sommer Hilde Heen   Østenstad Bjørn   Risberg Terje   Fjæstad Knut  

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 11-14

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine: In Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer

By Moen Marit D.   Wellington Keri  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

By Lobo Christopher   Lopes Gilberto   Baez Odalys   Castrellon Aurelio   Ferrell Annapoorna   Higgins Connie   Hurley Erin   Hurley Judith   Reis Isildinha   Richman Stephen   Seo Pearl   Silva Orlando   Slingerland Joyce   Tukia Keleni   Welsh Catherine   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 427-435

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study

By Jankowitz Rachel   Abraham Jame   Tan Antoinette   Limentani Steven   Tierno Marni   Adamson Laura   Buyse Marc   Wolmark Norman   Jacobs Samuel  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1205-1212

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by Denise A. Yardley

By Yardley Denise A.  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 334-335

Adis International

Access to resources Recommend Favorite